MetLife Investment Management’s Insulet PODD Stock Holding History
Bought
Maintained
Sold
Other funds holding PODD
MetLife Investment Management's PODD Position: Q2 2026 in Review
MetLife Investment Management reduced its Insulet (PODD) stake by 5.3% in Q2 2026, selling an estimated $173K and leaving 18,559 shares worth $2.83M. The position accounts for 0.01% of the portfolio, ranked #945.
MetLife Investment Management first reported a position in PODD in Q4 2017 and has held it in 23 quarters since. The position peaked at $6.63M in Q2 2025. 720 funds tracked by Wall St. Rank hold PODD as of Q2 2026.
- MetLife Investment Management held 18,559 shares of Insulet worth $2.83M as of Q2 2026.
- MetLife Investment Management sold 1,038 Insulet shares in Q2 2026, an estimated $173K.
- Insulet made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #945 holding.
- MetLife Investment Management first reported a position in Insulet in Q4 2017 and has held it in 23 quarters since.
- MetLife Investment Management's Insulet position peaked at $6.63M in Q2 2025.
- 720 funds tracked by Wall St. Rank held Insulet as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.